Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study academic.oup.com Submitted by burtzev t3_10vg0r8 on February 6, 2023 at 7:44 PM in science 22 comments 53
Viewing a single comment thread. View all comments